Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT

Recruiting now · Not applicable

Conditions studied: Major Depressive Disorder, Bipolar Disorder, Schizophrenia

In brief

This prospective, open-label clinical trial aims to compare a novel "Venous Tourniquet with Regional Low-Dose Sugammadex" method against the gold standard "Arterial Tourniquet" (Isolated Forearm Technique - IFT) for monitoring motor seizure activity during Electroconvulsive Therapy (ECT). Using a within-subject (intra-individual) design, each of the 40 enrolled patients will receive an arterial tourniquet on one arm and a venous tourniquet on the other arm simultaneously. The study will evaluate clinical efficacy in observing motor seizures, comparing the duration and visibility between the two limbs of the same patient, as well as assessing overall patient comfort and hemodynamics.

Key facts

Study ID

NCT07534475

Run by

Medipol University

People needed

20

Starts

2026-04-20

Expected to finish

2026-12-20

Last updated by the study team

2026-07-27

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients scheduled for elective Electroconvulsive Therapy (ECT).
• ASA (American Society of Anesthesiologists) physical status I to III.

You may not qualify if…

• Known neuromuscular diseases (e.g., Myasthenia Gravis).
• Known allergy or hypersensitivity to sugammadex, rocuronium, ketamine, dexmedetomidine, or propofol.
• Presence of venous insufficiency, lymphedema, or active infection in the upper extremities.
• Severe cardiovascular instability.

Where it is running

• Istanbul Medipol University — Istanbul, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.